Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Horwitz

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Science (New York, N.Y.)|July 3, 1981
Denizens of the AmazonR J Horwitz
Current Opinion in Immunology|August 1, 1992
Synthetic peptides as vaccinesR Arnon, R J Horwitz
Clinics in Chest Medicine|December 1, 1995
Inflammation and asthmaR J Horwitz, W W Busse
Cell|November 20, 1987
An elongation control particle containing the N gene transcriptional antitermination protein of bacteriophage lambdaR J Horwitz, J Li, J Greenblatt
Academic Medicine : Journal of the Association of American Medical Colleges|June 1, 1991
The acute care theater conferenceR J Horwitz, R G Christiansen, C Rogers
The American Journal of Medicine|September 1, 1985
Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditisJ W Mellors, R J Horwitz, D F Coleman
Vaccine|January 1, 1992
Synthetic recombinant vaccine expressing influenza haemagglutinin epitope in Salmonella flagellin leads to partial protection in miceJ McEwen, R Levi, R J Horwitz, et al.
American Journal of Respiratory and Critical Care Medicine|May 29, 1998
The role of leukotriene modifiers in the treatment of asthmaR J Horwitz, K A McGill, W W Busse
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 28, 1999
Leukotriene pathway inhibitors in asthma and chronic obstructive pulmonary diseaseW W Busse, K A McGill, R J Horwitz
Scandinavian Journal of Immunology|August 1, 1992
Peptide binding to class I molecules of the major histocompatibility complex on the surface of living target cellsU Kubitscheck, R Levi, R J Horwitz, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Science (New York, N.Y.)|July 3, 1981
Denizens of the AmazonR J Horwitz
Current Opinion in Immunology|August 1, 1992
Synthetic peptides as vaccinesR Arnon, R J Horwitz
Clinics in Chest Medicine|December 1, 1995
Inflammation and asthmaR J Horwitz, W W Busse
Cell|November 20, 1987
An elongation control particle containing the N gene transcriptional antitermination protein of bacteriophage lambdaR J Horwitz, J Li, J Greenblatt
Academic Medicine : Journal of the Association of American Medical Colleges|June 1, 1991
The acute care theater conferenceR J Horwitz, R G Christiansen, C Rogers
The American Journal of Medicine|September 1, 1985
Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditisJ W Mellors, R J Horwitz, D F Coleman
Vaccine|January 1, 1992
Synthetic recombinant vaccine expressing influenza haemagglutinin epitope in Salmonella flagellin leads to partial protection in miceJ McEwen, R Levi, R J Horwitz, et al.
American Journal of Respiratory and Critical Care Medicine|May 29, 1998
The role of leukotriene modifiers in the treatment of asthmaR J Horwitz, K A McGill, W W Busse
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 28, 1999
Leukotriene pathway inhibitors in asthma and chronic obstructive pulmonary diseaseW W Busse, K A McGill, R J Horwitz
Scandinavian Journal of Immunology|August 1, 1992
Peptide binding to class I molecules of the major histocompatibility complex on the surface of living target cellsU Kubitscheck, R Levi, R J Horwitz, et al.
Pageof 1